Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Fibroma (approved 2023)
Blood Protein Disorders (Phase 1/Phase 2)
Breast Neoplasms (Phase 2)
Corneal Diseases (Phase 1/Phase 2)
Fibromatosis, Aggressive (Phase 3)
Hematology (Phase 1/Phase 2)
HIV Infections (Phase 2)
Multiple Myeloma (Phase 2)
Neoplasms (Phase 3)
Neoplasms by Histologic Type (Phase 1)
Neoplasms, Plasma Cell (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Paraproteinemias (Phase 1/Phase 2)
Sarcoma, Kaposi (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue